Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/23/2025

Medical Necessity Determination for Chronic Rhinosinusitis Treatment

Introduction to Chronic Rhinosinusitis Treatment

  • The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2020 criteria suggest surgical intervention for chronic rhinosinusitis with nasal polyps lasting >12 weeks, failed appropriate medical therapy, objective evidence on CT scan, and endoscopic evidence of significant polyp burden 1

Medical Necessity for Specific Procedures

  • The American Academy of Otolaryngology recommends nasal endoscopy with maxillary antrostomy (CPT 31231) for patients with chronic rhinosinusitis with nasal polyps who have failed maximal medical therapy, including biologics, with >12 weeks duration, objective CT findings, and significant endoscopic disease 1, 2, 3
  • The American Academy of Allergy, Asthma, and Immunology suggests septoplasty (CPT 30520) may be likely supported for patients with septal deviation causing nasal obstruction and failed medical therapy for more than 4 weeks 3, 6
  • Pterygomaxillary fossa surgery (CPT 31040) is not supported due to no documented indication for pterygomaxillary fossa access, with no mass, tumor, or pathology requiring this approach 5, 7
  • Fracture nasal inferior turbinate (CPT 30930) is not supported as it does not meet MCG criteria, with primary pathology being middle turbinate polyps, not inferior turbinate hypertrophy requiring fracture 1, 2

Objective Evidence and Clinical Context

  • Objective evidence of disease on CT imaging, including left maxillary sinus mucus retention cyst or polyp, moderate ethmoid mucosal thickening, and opacification of ostiomeatal units, supports medical necessity for surgical intervention 4, 5
  • Endoscopic findings demonstrating bilateral polyps wrapping around middle turbinates, occluding 50-70% of airway above inferior turbinate, also support medical necessity 1

Guideline Recommendations

  • The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2020 recommends surgical intervention for patients with chronic rhinosinusitis with nasal polyps who have failed appropriate medical therapy, including biologics 1
  • Aetna Clinical Policy Bulletin 0937 suggests chronic rhinosinusitis >12 continuous weeks, failed maximal medical treatment, and objective evidence of disease by CT imaging support medical necessity for surgical intervention 3, 5

Summary of Medical Necessity

CPT Code Procedure Medical Necessity Rationale
31231 Nasal endoscopy with maxillary antrostomy SUPPORTED Meets criteria for CRSwNP with failed maximal medical therapy including biologics, >12 weeks duration, objective CT findings, significant endoscopic disease [1, 2, 3]
30520 Septoplasty LIKELY SUPPORTED Septal deviation with nasal obstruction, failed medical therapy >4 weeks [3, 6]
31040 Pterygomaxillary fossa surgery NOT SUPPORTED No documented indication for pterygomaxillary fossa access; no mass, tumor, or pathology requiring this approach [5, 7]
30930 Fracture nasal inferior turbinate NOT SUPPORTED Does not meet MCG criteria; primary pathology is middle turbinate polyps, not inferior turbinate hypertrophy requiring fracture [1, 2]